Consecuencias del consumo de cannabis. Revisión narrativa

  1. Vicente R. Ferri Reig
  2. Carmen María Sánchez Perona
  3. Aarati Vaswani Bolchand
  4. Miguel Galicia Paredes
  5. Guillermo Burillo-Putze
Journal:
Revista española de drogodependencias

ISSN: 0213-7615

Year of publication: 2022

Issue Title: Abordaje y actualización sobre el consumo de cannabis en la población española

Issue: 47

Pages: 37-49

Type: Article

More publications in: Revista española de drogodependencias

Abstract

Cannabis is the third most widely used drug worldwide, after alcohol and tobacco. In the current environment, with pressures for its legalisation, a narrative review was carried out based on recent literature to update the evidence on the effects of its recreational use. Nineteen articles on consequences at the organ level and six on harmful actions in the psychiatric sphere were selected. At the organ level, there is an association between cannabis use and cardiovascular pathology (AMI, stroke, arrhythmias and sudden death); at the respiratory level, there is an association with chronic bronchitis and altered lung volumes. Oncological risk has been seen with non-seminoma testicular cancer and increased likelihood of developing primary oropharyngeal cancer. In pregnancy, there is an association with the risk of low birth weight and increased neonatal ICU admissions. At the cognitive level, impairments in memory, attention and processing, as well as in driving have been demonstrated. At the psychiatric level, a relationship between cannabis use and the development of schizophrenia, psychosis and anxiety, together with depression, has been observed, with no change in their frequency and clinical presentation in the last 5 years.

Bibliographic References

  • Badowski, S. y Smith, G. (2020). Cannabis use during pregnancy and postpartum. Canadian Family Physician, 66(2), 98-103.
  • Belladelli, F., Del Giudice, F., Kasman, A., Kold Jensen, T., Jørgensen, N., Salonia, A. y Eisenberg, M. L. (2021). The association between cannabis use and testicular function in men: A systematic review and meta‐analysis. Andrology, 9(2), 503-510. https://doi.org/10.1111/andr.12953
  • Brubacher, J. R., Chan, H., Erdelyi, S., Staples, J. A., Asbridge, M. y Mann, R. E. (2022). Cannabis legalization and detection of tetrahydrocannabinol in injured drivers. New England journal of medicine, 386(2), 148-156. https://doi. org/10.1056/NEJMsa2109371
  • Chatkin, J. M., Zani-Silva, L., Ferreira, I. y Zamel, N. (2019). Cannabis-associated asthma and allergies. Clinical Reviews in Allergy & Immunology, 56(2), 196-206.
  • Cohen, K., Weizman, A. y Weinstein, A. (2019). Positive and negative effects of cannabis and cannabinoids on health. Clinical Pharmacology & Therapeutics, 105(5), 1139-1147. https://doi. org/10.1002/cpt.1381
  • Colizzi, M., Weltens, N., McGuire, P., Van Oudenhove, L. y Bhattacharyya, S. (2019). Descriptive psychopathology of the acute effects of intravenous delta9-tetrahydrocannabinol administration in humans. Brain Sciences, 9(4), 93. https:// doi.org/10.3390/brainsci9040093
  • Copeland, W. E., Hill, S. N. y Shanahan, L. (2022). Adult psychiatric, substance, and functional outcomes of different definitions of early cannabis use. Journal of the American Academy of Child & Adolescent Psychiatry, 61(4), 533-543. https://doi. org/10.1016/j.jaac.2021.07.824
  • De Faria, L., Mezey, L. y Winkler, A. (2021). Cannabis legalization and college mental health. Current psychiatry reports, 23(4), 1-9.
  • Drummer, O. H., Gerostamoulos, D. y Woodford, N. W. (2019). Cannabis as a cause of death: A review. Forensic science international, 298, 298-306. https://doi. org/10.1016/j.forsciint.2019.03.007
  • El Marroun, H., Brown, Q. L., Lund, I. O., Coleman-Cowger, V. H., Loree, A. M., Chawla, D. y Washio, Y. (2018). An epidemiological, developmental and clinical overview of cannabis use during pregnancy. Preventive medicine, 116, 1-5. https:// doi.org/10.1016/j.ypmed.2018.08.036
  • Ghosh, M. y Naderi, S. (2019). Cannabis and cardiovascular disease. Current atherosclerosis reports, 21(6), 1-6.
  • Gorelick, D. A. Cannabis use: Epidemiology, pharmacology, comorbidities, and adverse effects, 38. https://www.medilib. ir/uptodate/show/7797
  • Gunn, J. K. L., Rosales, C. B., Center, K. E., Nuñez, A., Gibson, S. J., Christ, C. y Ehiri, J. E. (2016). Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ open, 6(4), e009986. http://doi. org/10.1136/bmjopen-2015-009986
  • Guzman, M. (2003). Cannabinoids: potential anticancer agents. Nature reviews cancer, 3(10), 745-755. https://doi. org/10.1038/nrc1188
  • Hall, W. y Degenhardt, L. (2014). The adverse health effects of chronic cannabis use. Drug testing and analysis, 6(1-2), 39- 45. https://doi.org/10.1002/dta.1506
  • Hammond, C. J. (2022). Early Cannabis Exposure Definitions That Correspond With High Cumulative Lifetime Dose During Adolescence Are the Strongest Predictors of Adverse Health Outcomes. Journal of the American Academy of Child and Adolescent Psychiatry, 61(5), 612-614. https://doi:10.1016/j.jaac.2022.02.008
  • Jacobus, J., Courtney, K. E., Hodgdon, E. A. y Baca, R. (2019). Cannabis and the -developing brain: What does the evidence say?. Birth defects research, 111(17), 1302- 1307. https://doi.org/10.1002/bdr2.1572
  • Jengsuebsant, N., Benjachaya, S., Vuthiwong, J. y Tangsuwanaruk, T. (2022). Penile self-amputation due to cannabis-induced psychosis: a case report. Journal of medical case reports, 16(37), 1-4. https:// doi.org/10.1186/s13256-022-03267-0
  • Joshi, M., Joshi, A. y Bartter, T. (2014). Marijuana and lung diseases. Current opinion in pulmonary medicine, 20(2), 173-179. https://doi.org/10.1097/ MCP.0000000000000026
  • Marconi, A., Di Forti, M., Lewis, C. M., Murray, R. M. y Vassos, E. (2016). Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophrenia bulletin, 42(5), 1262-1269. https:// doi.org/10.1093/schbul/sbw003
  • Miech, R. A., Patrick, M. E., O’Malley, P. M., Johnston, L. D. y Bachman, J. G. (2020). Trends in reported marijuana vaping among US adolescents, 2017- 2019. Jama, 323(5), 475-476. https:// doi:10.1001/jama.2019.20185
  • Miller, N. S., Ipeku, R. y Oberbarnscheidt, T. (2020). A review of cases of marijuana and violence. International journal of environmental research and public health, 17(5), 1578. https://doi. org/10.3390/ijerph17051578
  • National Academies of Sciences Engineering and Medicine (2017). Committee on the health effects of marijuana: an evidence review and research agenda: the health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research.
  • Observatorio Español de las Drogas y las Adicciones. Estadísticas (2021). Alcohol, tabaco y drogas ilegales en España. Ministerio de Sanidad. Delegación del Gobierno para el Plan Nacional sobre Drogas; 213 p.
  • Reece, A. S. y Hulse, G. K. (2020). Co-occurrence across time and space of drugand cannabinoid-exposure and adverse mental health outcomes in the National Survey of Drug Use and Health: combined geotemporospatial and causal inference analysis. BMC public health, 20(1), 1-15. https://doi.org/10.1186/s12889- 020-09748-5
  • Roberts, B. A. (2019). Legalized cannabis in Colorado emergency departments: a cautionary review of negative health and safety effects. Western journal of emergency medicine, 20(4), 557. https://doi. org/10.5811/westjem.2019.4.39935
  • Santos-Álvarez, I., Pérez-Lloret, P., GonzálezSoriano, J. y Pérez-Moreno, M. (2021). Aproximación a la evaluación de la potencia de la resina de cannabis en Madrid: ¿Un riesgo para la salud? Adicciones. https:// doi.org/10.20882/adicciones.1630
  • Schmid, Y., Galicia, M., Vogt, S. B., Liechti, M. E., Burillo-Putze, G., Dargan, P. I., ... & Euro-DEN Plus Research Group) (2022). Differences in clinical features associated with cannabis intoxication in presentations to European emergency departments according to patient age and sex. Clinical toxicology, 60(8), 1-8. https://doi.org/10.1 080/15563650.2022.2060116
  • Self, T. H., Shah, S. P., March, K. L. y Sands, C. W. (2017). Asthma associated with the use of cocaine, heroin, and marijuana: A review of the evidence. Journal of Asthma, 54(7), 714-722. https://doi.org/10. 1080/02770903.2016.1259420
  • Simiyu, D. C., Jang, J. H. y Lee, O. R. (2022). Understanding Cannabis sativa L.: Current Status of Propagation, Use, Legalization, and Haploid-Inducer-Mediated Genetic Engineering. Plants, 11(9), 1236. https:// doi.org/10.3390/plants11091236
  • Stickrath, E. (2019). Marijuana use in pregnancy: an updated look at marijuana use and its impact on pregnancy. Clinical obstetrics and gynecology, 62(1), 185-190 https://doi. org/10.1097/GRF.0000000000000415
  • Subramaniam, V. N., Menezes, A. R., DeSchutter, A. y Lavie, C. J. (2019). The cardiovascular effects of marijuana: are the potential adverse effects worth the high?. Missouri medicine, 116(2), 146.
  • UNODC (1999). Bulletin on Narcotics - Volume LI, Nos. 1 and 2, 1999 - [Internet]. United Nations : Office on Drugs and Crime. Disponible en: https://www. unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1999-01-01_1.html
  • Volkow, N. D., Baler, R. D., Compton, W. M. y Weiss, S. R. (2014). Adverse health effects of marijuana use. New England Journal of Medicine, 370(23), 2219-2227. https:// doi.org/10.1056/NEJMra1402309
  • Xie, M., Gupta, M. K., Archibald, S. D., Stanley Jackson, B., Young, J. E. M. y Zhang, H. (2018). Marijuana and head and neck cancer: an epidemiological review. Journal of Otolaryngology-Head & Neck Surgery, 47(1), 1-7. https://doi. org/10.1186/s40463-018-0319-2